Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Other Non-Current Assets (2021 - 2022)

Marker Therapeutics (MRKR) has disclosed Other Non-Current Assets for 3 consecutive years, with $585840.0 as the latest value for Q4 2022.

  • On a quarterly basis, Other Non-Current Assets fell 46.74% to $585840.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $585840.0, a 46.74% decrease, with the full-year FY2022 number at $585840.0, down 46.74% from a year prior.
  • Other Non-Current Assets was $585840.0 for Q4 2022 at Marker Therapeutics, down from $1.1 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.1 million in Q4 2021 to a low of $585840.0 in Q4 2022.